Concepedia

Publication | Open Access

TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with <sup>89</sup>Zr-Fresolimumab PET

98

Citations

21

References

2015

Year

Abstract

(89)Zr-fresolimumab penetrated recurrent high-grade gliomas very well but did not result in clinical benefit.

References

YearCitations

Page 1